StreetAlpha.app
Home › Stocks › VCEL

Vericel Corp (VCEL)

$57.52
▼ −1.27%
LAST CLOSE · NOV 20

Vericel makes cell therapies and biologic products for knee cartilage repair and severe burn care. It last closed at $57.52 on Nov 20, down 1.27% on the day. The next earnings report for VCEL is expected around Tue, Jan 12, 2027. For the quarter ended Sep 2026, VCEL reported EPS of $0.27 on revenue of $85.4M, with revenue up 26.5% from a year ago. Over its last 8 reports the stock moved an average of 5.6% the session after earnings. Over the last 12 months VCEL insiders bought $0 of stock on the open market and sold $13.1M, according to SEC Form 4 filings.

AI Auto Pilots
Is VCEL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VCEL.

Key Stats

Last 12 months
Results
Revenue
$324.2M
+25.3% vs a year ago
Net income
$33.3M
+154.6% vs a year ago
EPS (diluted)
$0.64
+146.2% vs a year ago
Free cash flow
$57.9M
17.9% margin
Valuation
Market cap
$2.9B
51.0M shares
P/E
89.9
Price over 12 month EPS
Price to sales
9.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$133.5M
At Sep 30
Shareholder equity
$384.2M
Shares outstanding
51.0M
At Oct 29
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $156.2M$156.2MFY2021FY2022: $164.4M$164.4MFY2022FY2023: $197.5M$197.5MFY2023FY2024: $237.2M$237.2MFY2024FY2025: $276.3M$276.3MFY2025

From VCEL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Jan 12
Estimated date · Time not announced
Reported EPS
$0.27
Quarter ended Sep 2026
Year ago EPS
$0.10
+170.0% on a GAAP basis
Revenue
$85.4M
+26.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.39Dec '24Mar 2025: -$0.23Mar '25Jun 2025: -$0.01Jun '25Sep 2025: $0.10Sep '25Dec 2025: $0.45Dec '25Mar 2026: -$0.12Mar '26Jun 2026: $0.04Jun '26Sep 2026: $0.27Sep '26Latest $0.27
Revenue by quarter
Dec 2024: $75.4MDec '24Mar 2025: $52.6MMar '25Jun 2025: $63.2MJun '25Sep 2025: $67.5MSep '25Dec 2025: $92.9MDec '25Mar 2026: $68.4MMar '26Jun 2026: $77.5MJun '26Sep 2026: $85.4MSep '26Latest $85.4M
How VCEL moved after its last 8 reports
Average move the session after a report ±5.6%
Nov 5, 2026Time not announced+13.8%
Jul 30, 2026Time not announced+2.1%
May 7, 2026Time not announced−4.5%
Feb 26, 2026Time not announced+1.6%
Jan 13, 2026Time not announced+1.3%
Nov 6, 2025Time not announced+4.2%
Jul 31, 2025Time not announced−14.1%
May 8, 2025Time not announced+3.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on VCELStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on VCEL
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on VCEL

Technical Analysis

VCEL · as of the Nov 20 close · updated each morning
Uptrend, overbought

The stock is 11% above its 20 day and 22% above its 50 day average. It is 31% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 71), overbought. The nearest support is the Pivot S1 at $56.74, and the nearest resistance the Pivot at $58.11.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 4.0%/day
Key levels
$59.7552 week high+3.9%
$59.75Swing high (Nov 11)+3.9%
$58.89Pivot R1+2.4%
$58.11Pivot+1.0%
$57.52Last close
$56.74Pivot S1−1.4%
$56.71Swing low (Nov 16)−1.4%
$51.2520 day average−10.9%
$44.6950 day average−22.3%
$44.43100 day average−22.8%
$39.94200 day average−30.6%
$28.9552 week low−49.7%
Indicators
RSI (14)70.85Overbought above 70Overbought
MACD4.45Above its signal lineBullish
Stochastic91.9Near the top of its rangeOverbought
ADX (14)44.1Strong uptrend
Williams %R-11.4Oversold below −80, overbought above −20Overbought
CCI (20)63.2Oversold below −100, overbought above 100Neutral
Rate of change+5.3%Change over 10 sessionsBullish
ATR (14)$2.31Typical daily range, 4.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for VCEL

What happened before

See how VCEL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow VCEL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How VCEL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for VCELHow many large options trades hit VCEL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

VCEL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●164 buying vs 145 selling
  • ▲Held by funds +1.7 pts
  • ●Funds holding -2
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding320322−0.6%
In funds' top 10220.0%
Held by funds110.7%108.9%+1.7 pts
New / increased39 / 12563 / 122−11.4%
Reduced / sold out103 / 42101 / 22+17.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See VCEL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

VCEL Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$13.1M30 sales · 9 insiders
95% of the selling was under pre-arranged trading plans.
2025-12 sold $254K2026-01 sold $405K2026-02 sold $243K2026-03 sold $1.6M2026-04 sold $122K2026-05 sold $948K2026-06 sold $2.6M2026-07 sold $220K2026-08 sold $780K2026-11 sold $5.9MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 13Jonathan SiegalPrincipal Accounting OfficerSale1,885$57.71$109K
Nov 11Joseph Anthony Mara JrCFOSale plan25,008$58.26$1.5M
Nov 10Kevin F MclaughlinDirectorSale plan7,000$58.96$413K
Nov 9Robert L Zerbe MdDirectorSale plan2,000$57.88$116K
Nov 6Joseph Anthony Mara JrCFOSale plan50,000$53.48$2.7M
Nov 5Robert L Zerbe MdDirectorSale plan5,500$49.12$270K
Every insider buy and sale for VCEL over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See VCEL insider trades →

From SEC Form 4 filings by VCEL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VCEL is in one of them and how their past VCEL trades turned out.

VCEL in the AI portfolios
Loading…

VCEL News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VCEL in an article yet. Here's the latest on the wider market.

VCEL in the news

About Vericel

Vericel is a company in Burlington, Massachusetts that makes cell therapy and specialty biologic products for sports medicine and severe burn care. Its MACI product is an implant made from a patient's own cells that orthopedic surgeons use to repair knee cartilage. Epicel is a permanent skin replacement for severe burns, and NexoBrid is a product applied to burns to remove damaged tissue. Its customers include orthopedic surgeons and burn centers in the United States.

Headquarters
Burlington, MA